| scholarly article | Q13442814 |
| P50 | author | Edythe D. London | Q5346986 |
| Mark S. Cohen | Q16187017 | ||
| Arthur L Brody | Q92443172 | ||
| Jennifer Bramen | Q125297839 | ||
| Stephanie Shulenberger | Q125317049 | ||
| P2093 | author name string | Mark A Mandelkern | |
| Matthew R Costello | |||
| Joanna J Gan | |||
| Richard E Olmstead | |||
| Christopher S Culbertson | |||
| P2860 | cites work | Is the mirror neuron system involved in imitation? A short review and meta-analysis | Q22337337 |
| Antidepressants for smoking cessation | Q24245969 | ||
| Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels | Q24561829 | ||
| A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor | Q24563250 | ||
| Behavioral and biochemical investigations of bupropion metabolites | Q28156301 | ||
| A three-dimensional statistical analysis for CBF activation studies in human brain | Q29010822 | ||
| Neural systems of reinforcement for drug addiction: from actions to habits to compulsion | Q29547251 | ||
| Cognitive and emotional influences in anterior cingulate cortex | Q29547440 | ||
| Improved optimization for the robust and accurate linear registration and motion correction of brain images | Q29547542 | ||
| Fast robust automated brain extraction | Q29615078 | ||
| A global optimisation method for robust affine registration of brain images | Q29615079 | ||
| Predictive reward signal of dopamine neurons | Q29615397 | ||
| The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire | Q29615435 | ||
| Development of a Rating Scale for Primary Depressive Illness | Q29616244 | ||
| Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study | Q30411127 | ||
| Temporal autocorrelation in univariate linear modeling of FMRI data | Q30665534 | ||
| Instructed smoking expectancy modulates cue-elicited neural activity: a preliminary study | Q30998675 | ||
| The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion. | Q32060246 | ||
| Bayesian analysis of neuroimaging data in FSL. | Q33390048 | ||
| Magnetic resonance imaging studies of cigarette smoking | Q33404671 | ||
| Breath carbon monoxide and semiquantitative saliva cotinine as biomarkers for smoking | Q33584845 | ||
| 24-h smoking abstinence potentiates fMRI-BOLD activation to smoking cues in cerebral cortex and dorsal striatum | Q33607733 | ||
| Effects of treatment for tobacco dependence on resting cerebral glucose metabolism | Q33620732 | ||
| Bupropion: a review of its use in the management of smoking cessation | Q33914387 | ||
| Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment | Q34057373 | ||
| Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour. | Q34188083 | ||
| In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography | Q34269010 | ||
| Bupropion: a review of its mechanism of antidepressant activity | Q34304510 | ||
| Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors | Q34342464 | ||
| How does bupropion work as a smoking cessation aid? | Q34444129 | ||
| Cue dependency of nicotine self-administration and smoking. | Q34498025 | ||
| Bupropion is a nicotinic antagonist. | Q34510864 | ||
| A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation | Q34535460 | ||
| Bupropion: pharmacology and therapeutic applications | Q34569990 | ||
| Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine | Q34756084 | ||
| Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions? | Q34984980 | ||
| Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues | Q35040937 | ||
| Bupropion as an aid to smoking cessation: a review of real-life effectiveness. | Q35760138 | ||
| DAT genotype modulates brain and behavioral responses elicited by cigarette cues. | Q35947872 | ||
| Neural substrates of resisting craving during cigarette cue exposure. | Q36011544 | ||
| Reactivity to smoking cues and relapse: Two studies of discriminant validity | Q52252998 | ||
| Nicotine blood levels and subjective craving for cigarettes. | Q52278652 | ||
| Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis | Q69125845 | ||
| Desire to smoke during spaced smoking intervals | Q70795350 | ||
| Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism | Q72495309 | ||
| A comparison of sustained-release bupropion and placebo for smoking cessation | Q73804709 | ||
| Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area | Q36122868 | ||
| Nicotine as a typical drug of abuse in experimental animals and humans. | Q36277268 | ||
| Neural substrates of abstinence-induced cigarette cravings in chronic smokers | Q36298171 | ||
| The orbital prefrontal cortex and drug addiction in laboratory animals and humans | Q36936602 | ||
| Review. Neurobiology of nicotine dependence | Q37024161 | ||
| The relevance and treatment of cue-induced cravings in tobacco dependence | Q37248093 | ||
| An fMRI investigation of the impact of withdrawal on regional brain activity during nicotine anticipation | Q37253284 | ||
| A survey of tobacco dependence treatment guidelines in 31 countries | Q37329473 | ||
| Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment | Q37353350 | ||
| Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study | Q37412707 | ||
| Nicotinic receptor-based therapeutics and candidates for smoking cessation | Q37518024 | ||
| Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits | Q37533310 | ||
| Clinical and laboratory assessment of the subjective experience of drug craving | Q37541430 | ||
| The role of nicotine in smoking: a dual-reinforcement model. | Q41559912 | ||
| Attenuation of cue-induced smoking urges and brain reward activity in smokers treated successfully with bupropion. | Q43300290 | ||
| Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. | Q43739992 | ||
| The effect of bupropion sustained-release on cigarette craving after smoking cessation | Q43997773 | ||
| Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging | Q44013086 | ||
| Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial | Q44073607 | ||
| Investigating the actions of bupropion on dependence-related effects of nicotine in rats | Q44228871 | ||
| Brain metabolic changes during cigarette craving | Q44241351 | ||
| Subsecond dopamine release promotes cocaine seeking. | Q44398175 | ||
| Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial | Q44633869 | ||
| Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments | Q44941634 | ||
| Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers | Q45011603 | ||
| Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial | Q45022780 | ||
| Bupropion for smoking cessation: a randomized trial | Q45056925 | ||
| Nicotinic receptor subtypes in rat hippocampal slices are differentially sensitive to desensitization and early in vivo functional up-regulation by nicotine and to block by bupropion | Q45221690 | ||
| Brain regions related to tool use and action knowledge reflect nicotine dependence | Q46049773 | ||
| Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery | Q46679009 | ||
| A functional magnetic resonance imaging (FMRI) study of cue-induced smoking craving in virtual environments | Q46706801 | ||
| Outcomes of bupropion therapy for smoking cessation during routine clinical use. | Q46910066 | ||
| Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues | Q46911648 | ||
| Precessation treatment with nicotine skin patch facilitates smoking cessation | Q46960275 | ||
| General multilevel linear modeling for group analysis in FMRI. | Q47433848 | ||
| Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study | Q48233950 | ||
| Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli | Q48457465 | ||
| Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study | Q48591912 | ||
| The effect of bupropion on nicotine craving and withdrawal | Q48732462 | ||
| A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation | Q48770780 | ||
| The precuneus/posterior cingulate cortex plays a pivotal role in the default mode network: Evidence from a partial correlation network analysis | Q49125412 | ||
| The Leeds scales for the self-assessment of anxiety and depression. | Q50914862 | ||
| The impact of imagining personalized versus standardized urge scenarios on cigarette craving and autonomic reactivity. | Q51058658 | ||
| Multilevel linear modelling for FMRI group analysis using Bayesian inference. | Q52000514 | ||
| Nicotine reinstatement of nicotine self-administration after long-term extinction. | Q52200047 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 505-515 | |
| P577 | publication date | 2011-01-03 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers | |
| P478 | volume | 68 |
| Q37163680 | Acute baclofen diminishes resting baseline blood flow to limbic structures: a perfusion fMRI study |
| Q41507939 | All cravings are not created equal |
| Q37169216 | Biomarkers for smoking cessation |
| Q40435917 | Can repetitive mental simulation of smoking engender habituation? |
| Q40612069 | Cigarette smoking leads to persistent and dose-dependent alterations of brain activity and connectivity in anterior insula and anterior cingulate |
| Q50765889 | Comparison of craving between smoked and smokeless tobacco across a variety of cue exposures. |
| Q45947999 | Decoding the encoding of functional brain networks: An fMRI classification comparison of non-negative matrix factorization (NMF), independent component analysis (ICA), and sparse coding algorithms. |
| Q34958609 | Deconstructing craving: dissociable cortical control of cue reactivity in nicotine addiction |
| Q26823158 | Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications |
| Q51245385 | Effect of combined naltrexone and bupropion therapy on the brain's functional connectivity. |
| Q59127593 | Functional brain activation changes associated with practice in delaying smoking among moderate to heavy smokers: study protocol and rationale of a randomized trial (COPE) |
| Q34323820 | Functional, structural, and emotional correlates of impaired insight in cocaine addiction |
| Q58804210 | Heat or Burn? Impacts of Intrauterine Tobacco Smoke and E-Cigarette Vapor Exposure on the Offspring's Health Outcome |
| Q34623225 | Impaired self-awareness in human addiction: deficient attribution of personal relevance |
| Q37325773 | Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion |
| Q30678836 | Integrating ecological momentary assessment and functional brain imaging methods: new avenues for studying and treating tobacco dependence. |
| Q39446865 | Intra-individual changes in Stroop-related activations linked to cigarette abstinence in adolescent tobacco smokers: Preliminary findings |
| Q35484479 | Large Sample Group Independent Component Analysis of Functional Magnetic Resonance Imaging Using Anatomical Atlas-Based Reduction and Bootstrapped Clustering |
| Q51244728 | Naltrexone and Bupropion Combination Treatment for Smoking Cessation and Weight Loss in Patients With Schizophrenia. |
| Q30655273 | Neural bases of pharmacological treatment of nicotine dependence - insights from functional brain imaging: a systematic review |
| Q37017654 | Neural circuitry of impulsivity in a cigarette craving paradigm |
| Q33738824 | Neural correlates of attentional bias for smoking cues: modulation by variance in the dopamine transporter gene |
| Q26782278 | Neural substrates of cue reactivity: association with treatment outcomes and relapse |
| Q35782682 | Neural substrates of smoking cue reactivity: a meta-analysis of fMRI studies |
| Q35215311 | Neuroimaging craving: urge intensity matters |
| Q31096451 | Neuroimaging the Effectiveness of Substance Use Disorder Treatments |
| Q34714494 | Neuroscience of behavioral and pharmacological treatments for addictions |
| Q31043230 | Noninvasive brain stimulation treatments for addiction and major depression |
| Q49977148 | Pharmacological intervention and abstinence in smokers undergoing cessation treatment: A psychophysiological study. |
| Q48656410 | Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind study |
| Q30455941 | Subjective reactivity to smoking cues as a predictor of quitting success |
| Q30587123 | The association between cue-reactivity in the precuneus and level of dependence on nicotine and alcohol |
| Q33746818 | The development and expression of physical nicotine dependence corresponds to structural and functional alterations in the anterior cingulate-precuneus pathway |
| Q36201529 | The relationships among individual and regional smoking, socioeconomic status, and oral and pharyngeal cancer survival: a mediation analysis |
| Q47642738 | Transcranial magnetic stimulation of the dorsal lateral prefrontal cortex inhibits medial orbitofrontal activity in smokers. |
| Q35195302 | Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings. |
| Q30519505 | Volitional reduction of anterior cingulate cortex activity produces decreased cue craving in smoking cessation: a preliminary real-time fMRI study. |
Search more.